CND Life Sciences: Hernan Lopez, Kathryn Van Wie, Annemarie Benton, Bryan May

Neurodegenerative disease diagnostic firm CND Life Sciences this week said Hernan Lopez has joined the company as chief operating officer, while Kathryn Van Wie has been appointed VP of strategy and business development, Annemarie Benton was named VP of market access, and Bryan May was named VP of information technology.

Lopez has almost 20 years of experience with medical device and life science companies, and prior to joining CND, he was EVP of operations at GT Medical Technology. Meanwhile, Van Wie is an attorney who spent a decade at Vertex Pharmaceuticals as corporate counsel, then subsequently in US marketing and as chief of staff in commercial strategy and operations.

Benton was head of managed care at Bionano Genomics before moving to CND, and May was at Atara Biotherapeutics where he supported infrastructure and cloud services.